Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the hypothesis that the efficacy of intravenous (IV) itraconazole followed by oral itraconazole is non-inferior to that of intravenous caspofungin as empiric therapy for suspected fungal infection participants with fever and neutropenia.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02895529
Study type Interventional
Source Xian-Janssen Pharmaceutical Ltd.
Status Terminated
Phase Phase 4
Start date November 30, 2016
Completion date May 2, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03735992 - Mind-body Medicine for Patients With Malignant Hematological Diseases N/A
Terminated NCT00957580 - Trial of Pimasertib in Hematological Malignancies Phase 2
Completed NCT00997386 - Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States Phase 2
Completed NCT00389428 - Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer. Phase 1
Active, not recruiting NCT02193880 - Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) N/A
Recruiting NCT02650791 - Platelet Transfusion Requirements in Hematopoietic Transplantation Phase 3
Active, not recruiting NCT01362179 - National Marrow Donor Program Long-Term Donor Follow-Up
Active, not recruiting NCT02900248 - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting NCT00071045 - Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Recruiting NCT03320915 - Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT Phase 2
Recruiting NCT03083327 - Prophylactic Early PN in HPT/BMT N/A
Recruiting NCT03743480 - Early Palliative Care and Hematological Cancer Patients N/A
Not yet recruiting NCT03680092 - Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy Phase 2
Not yet recruiting NCT03722186 - Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies Phase 1
Completed NCT02635984 - Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens Phase 3
Completed NCT01275534 - Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation N/A
Recruiting NCT01332006 - Intra-bone Cord Blood Transplantation Phase 2
Completed NCT03349372 - Impact of Pulmonary Follow-up After Stem Cell Graft N/A
Completed NCT03575767 - Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT
Completed NCT00038376 - Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies Phase 2